Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception

Human Gene Therapy

Volumn 24, Issue 2, 2013, Pages 170-180

  Yokoyama, Hitoshi ^a,b   Oguchi, Tomohiko ^a,b   Goins, William F ^a   Goss, James R ^a,c   Nishizawa, Osamu ^b   De Groat, William C ^a   Wolfe, Darren ^c   Krisky, David M ^c   Glorioso, Joseph C ^a   Yoshimura, Naoki ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Diamyd Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPESVIRUS VECTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; NALOXONE; PREPROENKEPHALIN; PROTEIN C FOS; RESINIFERATOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER WALL; CONTROLLED STUDY; CYSTOMETRY; FEMALE; GENE THERAPY; HERPES SIMPLEX VIRUS; INNERVATION; NOCICEPTION; NONHUMAN; OVERACTIVE BLADDER; RAT; SPINAL GANGLION; TRANSGENE;

ANALGESICS; ANIMALS; DITERPENES; ENKEPHALINS; FEMALE; GANGLIA, SPINAL; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; NALOXONE; NOCICEPTION; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIMPLEXVIRUS; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINARY CATHETERIZATION; VIRUS REPLICATION; VISCERAL PAIN;

EID: 84874295170     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.180     Document Type: Article

References (57)

1. Akkaraju, G.R., Huard, J., Hoffman, E.P., et al. (1999). Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle. J. Gene Med. 1, 280-289.
2. Birder, L.A., and de Groat, W.C. (1992). Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat. J. Neurosci. 12, 4878-4889.
3. Bouchelouche, K., Alvarez, S., Andersen, L., et al. (2004). Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells. J. Urol. 171, 462-466.
4. Braz, J., Beaufour, C., Coutaux, A., et al. (2001). Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J. Neurosci. 21, 7881-7888.
5. Burton, E.A., Bai, Q., Goins, W.F., and Glorioso, J.C. (2002). Replication-defective genomic herpes simplex vectors: design and production. Curr. Opin. Biotechnol. 13, 424-428.
6. Chen, M.C., Keshavan, P., Gregory, G.D., and Klumpp, D.J. (2007). RANTES mediates TNF-dependent lamina propria mast cell accumulation and barrier dysfunction in neurogenic cystitis. Am. J. Physiol. Renal Physiol. 292, F1372-F1379.
7. Coggeshall, R.E., Zhou, S., and Carlton, S.M. (1997). Opioid receptors on peripheral sensory axons. Brain Res. 764, 126-132.
8. Conti, P., Pang, X., Boucher, W., et al. (1997). Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89, 4120-4127.
9. Copray, J.C., Mantingh, I., Brouwer, N., et al. (2001). Expression of interleukin-1 beta in rat dorsal root ganglia. J. Neuroimmunol. 118, 203-211.
10. Craft, R.M., Carlisi, V.J., Mattia, A., et al. (1993). Behavioral characterization of the excitatory and desensitizing effects of intravesical capsaicin and resiniferatoxin in the rat. Pain 55, 205-215.
11. Cruz, F., Avelino, A., Lima, D., and Coimbra, A. (1994). Activation of the c-fos proto-oncogene in the spinal cord following noxious stimulation of the urinary bladder. Somatosens. Mot. Res. 11, 319-325.
12. Cruz, F., Avelino, A., and Coimbra, A. (1996). Desensitization follows excitation of bladder primary afferents by intravesical capsaicin, as shown by c-fos activation in the rat spinal cord. Pain 64, 553-557.
13. Dray, A., Nunan, L., and Wire, W. (1985). Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat. Br. J. Pharmacol. 85, 717-726.
14. Elliott, T.E., Renier, C.M., and Palcher, J.A. (2003). Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med. 4, 331-339.
15. Erickson, D.R. (1999). Interstitial cystitis: update on etiologies and therapeutic options. J. Womens Health Gend. Based Med. 8, 745-758.
16. Erickson, D.R., Xie, S.X., Bhavanandan, V.P., et al. (2002). A comparison of multiple urine markers for interstitial cystitis. J. Urol. 167, 2461-2469.
17. Fink, D.J., DeLuca, N.A., Yamada, M., et al. (2000). Design and application of HSV vectors for neuroprotection. Gene Ther. 7, 115-119.
18. Fink, D.J., Wechuck, J., Mata, M., et al. (2011). Gene therapy for pain: results of a phase I clinical trial. Ann. Neurol. 70, 207-212.
19. Foley, K.M. (1993). Opioid analgesics in clinical pain management. In Opioid II: Handbook of Experimental Pharmacology. A. Herz, H. Akil, and E.J. Simon, eds. (Springer-Verlag, New York) pp. 697-744.
20. Goins, W.F., Lee, K.A., Cavalcoli, J.D., et al. (1999). Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J. Virol. 73, 519-532.
21. Goins, W.F., Goss, J.R., Chancellor, M.B., et al. (2009). Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain. Gene Ther. 16, 558-569.
22. Goss, J.R., Mata, M., Goins, W.F., et al. (2001). Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther. 8, 551-556.
23. Goss, J.R., Harley, C.F., Mata, M., et al. (2002). Herpes vectormediated expression of proenkephalin reduces bone cancer pain. Ann. Neurol. 52, 662-665.
24. Hao, S., Mata, M., Goins, W., et al. (2003). Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain 102, 135-142.
25. Hisamitsu, T., and de Groat, W.C. (1984). The inhibitory effect of opioid peptides and morphine applied intrathecally and intracerebroventricularly on the micturition reflex in the cat. Brain Res. 298, 51-65.
26. Inoue, A., Ikoma, K., Morioka, N., et al. (1999). Interleukin-1b induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J. Neurochem. 73, 2206-2213.
27. Jung, H., Toth, P.T., White, F.A., and Miller, R.J. (2008). Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J. Neurochem. 104, 254-263.
28. Katz, W.A., and Barkin, R.L. (2010). Dilemmas in chronic/persistent pain management. Dis. Mon. 56, 233-250.
29. Krisky, D.M., Marconi, P.C., Oligino, T.J., et al. (1998a). Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther. 5, 1517-1530.
30. Krisky, D.M., Wolfe, D., Goins, W.F., et al. (1998b). Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 5, 1593-1603.
31. Lamale, L.M., Lutgendorf, S.K., Zimmerman, M.B., and Kreder, K.J. (2006). Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis. Urology 68, 702-706.
32. Lecci, A., Giuliani, S., Lazzeri, M., et al. (1994). The behavioral response induced by intravesical instillation of capsaicin rats is mediated by pudendal urethral sensory fibers. Life Sci. 55, 429-436.
33. Lilley, C.E., Groutsi, F., Han, Z., et al. (2001). Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J. Virol. 75, 4343-4356.
34. Lotz, M., Vaughan, J.H., and Carson, D.A. (1988). Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241, 1218-1221.
35. Lu, Y., McNearney, T.A., Lin, W., et al. (2007). Treatment of inflamed pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae. Mol. Ther. 15, 1812-1819.
36. Marconi, P., Krisky, D., Oligino, T., et al. (1996). Replicationdefective herpes simplex virus vectors for gene transfer in vivo. Proc. Natl. Acad. Sci. U.S.A. 93, 11319-11320.
37. Mellerick, D.M., and Fraser, N.W. (1987). Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virology 158, 265-275.
38. Mousa, S.A., Zhang, Q., Sitte, N., et al. (2001). b-Endorphincontaining memory-cells and l-opioid receptors undergo transport to peripheral inflamed tissue. J. Neuroimmunol. 115, 71-78.
39. Murphy, D.B., McCartney, C.J., and Chan, V.W. (2000). Novel analgesic adjuncts for brachial plexus block: a systematic review. Anesth. Analg. 90, 1122-1128.
40. Niv, D., and Devor, M. (2004). Chronic pain as a disease in its own right. Pain Pract. 4, 179-181.
41. Obreja, O., Schmelz, M., Poole, S., and Kress, M. (2002). Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain 96, 57-62.
42. Oligino, T., Ghivizzani, S., Wolfe, D., et al. (1999). Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther. 6, 1713-1720.
43. Park, M., Kim, J., Bae, Y., et al. (1997). CNS innervation of the urinary bladder demonstrated by immunohistochemical study for c-fos and pseudorabies virus. J. Korean Med. Sci. 12, 340-352.
44. Picard, P.R., Tramer, M.R., McQuay, H.J., and Moore, R.A. (1997). Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials. Pain 72, 309-318.
45. Ratner, V. (2001). Interstitial cystitis: a chronic inflammatory bladder condition. World J. Urol. 19, 157-159.
46. Saitoh, C., Chancellor, M.B., de Groat, W.C., and Yoshimura, N. (2008). Effects of intravesical instillation of resiniferatoxin on bladder function and nociceptive behavior in freely moving, conscious rats. J. Urol. 179, 359-364.
47. Samaniego, L.A., Neiderhiser, L., and DeLuca, N.A. (1998). Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72, 3307-3320.
48. Smaldone, M.C., Vodovotz, Y., Tyagi, V., et al. (2009). Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis. Urology 73, 421-426.
49. Sommer, C., and Kress, M. (2004). Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. 361, 184-187.
50. Srinivasan, R., Huang, S., Chaudhry, S., et al. (2007). An HSV vector system for selection of ligand-gated ion channel modulators. Nat. Methods 4, 733-739.
51. Stein, C., Pfluger, M., Yassouridis, A., et al. (1996). No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J. Clin. Invest. 98, 793-799.
52. Stein, C., Machelska, H., and Schafer, M. (2001). Peripheral analgesic and antiinflammatory effects of opioids. Z. Rheumatol. 60, 416-424.
53. Way, E.L. (1993). Opioid tolerance and physical dependence and their relationship. In Opioid II: Handbook of Experimental Pharmacology. A. Herz, H. Akil, and E.J. Simon, eds. (Springer-Verlag, New York) pp. 573-596.
54. Wenk, H.N., and Honda, C.N. (1999). Immunohistochemical localization of delta opioid receptors in peripheral tissues. J. Comp. Neurol. 408, 567-579.
55. Wilson, S.P., Yeomans, D.C., Bender, M.A., et al. (1999). Antihyperalgesic effects of infection with a preproenkephalinencoding herpes virus. Proc. Natl. Acad. Sci. U.S.A. 96, 3211-3216.
56. Yang, H., McNearney, T.A., Chu, R., et al. (2008). Enkephalinencoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model. Mol. Pain 4, 8.
57. Yokoyama, H., Sasaki, K., Franks, M.E., et al. (2009). Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Hum. Gene Ther. 20, 63-71.